A PHASE I/II STUDY OF ADOPTIVE T-CELL THERAPY (ALT) AND DC VACCINATION (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY AND HEMATOPOIETIC STEM CELL TRANSPLANTATION (HDC plus ASCR) OR NON-MYELOABLATIVE CONDITIONING (NMA) IN PATIENTS (PTS) WITH RECURRENT CENTRAL PNETS (RE-MATCH PROTOCOL)
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D
Published Date
- April 1, 2013
Published In
Volume / Issue
- 15 /
Start / End Page
- 46 - 47
Published By
Pages
- 2
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- 2nd Annual Pediatric Neuro-Oncology Basic and Translational Research Conference
Conference Location
- Fort Lauderdale, FL
Conference Start Date
- May 16, 2013
Conference End Date
- May 17, 2013